AVBP

ArriVent BioPharma, Inc. - Common Stock (AVBP)

About ArriVent BioPharma, Inc. - Common Stock (AVBP)

Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company. It focuses on identifying, licensing and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.

Details

Daily high
$19.69
Daily low
$17.43
Price at open
$17.86
52 Week High
$36.37
52 Week Low
$14.35
Market cap
617.1M
Dividend yield
0.00%
Volume
202,634
Avg. volume
271,008
P/E ratio
-7.57

ArriVent BioPharma, Inc. - Common Stock News

Details

Daily high
$19.69
Daily low
$17.43
Price at open
$17.86
52 Week High
$36.37
52 Week Low
$14.35
Market cap
617.1M
Dividend yield
0.00%
Volume
202,634
Avg. volume
271,008
P/E ratio
-7.57